Position in NVS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$8,739,020
+$188,228 QoQ
Shares Held
55,762
-0.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#186
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PINNACLE ASSOCIATES LTD holds $673,247,849 across 14 Drug Manufacturers - General names. NVS ranks #8 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,656,912 | $420,805,940 | |
| 2 | LLY |
ELI LILLY & Co
|
62,043 | $74,416,241 | |
| 3 | MRK |
Merck & Co., Inc.
|
486,775 | $62,550,587 | |
| 4 | ABBV |
AbbVie Inc.
|
186,566 | $46,947,468 | |
| 5 | AMGN |
Amgen Inc
|
62,102 | $22,488,376 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
104,077 | $13,149,088 | |
| 7 | PFE |
Pfizer Inc
|
378,796 | $9,121,407 | |
| 8 | NVS |
Novartis AG
This page
|
55,762 | $8,739,020 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,739,020 | 55,762 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $8,550,792 | 55,979 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $7,886,853 | 57,205 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $7,414,195 | 57,815 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $7,027,655 | 58,075 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $6,543,987 | 58,701 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $5,714,043 | 58,720 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,016,220 | 61,000 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $6,275,817 | 58,950 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $5,812,699 | 60,092 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $6,159,170 | 61,000 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $6,235,869 | 61,220 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $6,307,379 | 62,505 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $5,866,932 | 63,771 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $5,860,512 | 64,600 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $4,869,200 | 64,060 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $5,555,734 | 65,725 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $5,818,527 | 66,308 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $5,823,840 | 66,581 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $6,032,092 | 73,760 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $6,843,456 | 75,005 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $6,473,400 | 75,730 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $7,299,627 | 77,302 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $6,709,311 | 77,154 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $6,687,187 | 76,565 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $6,414,115 | 77,794 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||